Does GOSERELIN Cause Hormone-refractory prostate cancer? 8 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Hormone-refractory prostate cancer have been filed in association with GOSERELIN (ZOLADEX). This represents 0.1% of all adverse event reports for GOSERELIN.
8
Reports of Hormone-refractory prostate cancer with GOSERELIN
0.1%
of all GOSERELIN reports
3
Deaths
0
Hospitalizations
How Dangerous Is Hormone-refractory prostate cancer From GOSERELIN?
Of the 8 reports, 3 (37.5%) resulted in death.
Is Hormone-refractory prostate cancer Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GOSERELIN. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does GOSERELIN Cause?
Death (1,293)
Malignant neoplasm progression (935)
Metastases to bone (397)
Neutropenia (339)
Fatigue (309)
Off label use (272)
Metastases to liver (264)
Hot flush (263)
Asthenia (213)
Arthralgia (190)
What Other Drugs Cause Hormone-refractory prostate cancer?
RADIUM RA-223 DICHLORIDE (441)
LEUPROLIDE (180)
DOCETAXEL (123)
ENZALUTAMIDE (120)
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN (110)
DAROLUTAMIDE (104)
ABIRATERONE (83)
PREDNISONE (58)
CABAZITAXEL (57)
BICALUTAMIDE (50)
Which GOSERELIN Alternatives Have Lower Hormone-refractory prostate cancer Risk?
GOSERELIN vs GRAMICIDIN
GOSERELIN vs GRAMICIDIN\NEOMYCIN\POLYMYXIN B
GOSERELIN vs GRAMICIDIN\POLYMYXIN B
GOSERELIN vs GRANISETRON
GOSERELIN vs GRANULOCYTE COLONY-STIMULATING FACTOR NOS